Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,290 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $277.53 | 9 | $0 (2024) |
| ABBVIE INC. | $185.65 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $170.88 | 9 | $0 (2024) |
| Novo Nordisk Inc | $149.93 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $123.21 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $95.39 | 3 | $0 (2024) |
| Eisai Inc. | $91.27 | 4 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $59.89 | 3 | $0 (2024) |
| Grifols USA, LLC | $45.17 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $28.43 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.24 | 21 | Veloxis Pharmaceuticals, Inc. ($187.93) |
| 2023 | $430.29 | 19 | ABBVIE INC. ($130.57) |
| 2022 | $314.99 | 11 | Gilead Sciences, Inc. ($123.21) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: TRANSPLANTATION | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Rare Disease | ||||||
| 10/29/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: TRANSPLANTATION | ||||||
| 10/28/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/17/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: TRANSPLANTATION | ||||||
| 09/09/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Rare Disease | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Infectious Diseases | ||||||
| 07/30/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: TRANSPLANTATION | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Rare Disease | ||||||
| 06/18/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: TRANSPLANTATION | ||||||
| 06/18/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Rare Disease | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Infectious Diseases | ||||||
| 05/23/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: CRITICAL CARE | ||||||
| 05/21/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: TRANSPLANTATION | ||||||
| 04/30/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Rare Disease | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Rare Disease | ||||||
| 01/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: VIROLOGY | ||||||
| 10/17/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: VIROLOGY | ||||||
| 09/08/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: VIROLOGY | ||||||
| 08/10/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VIROLOGY | ||||||
| 08/02/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 35 | $13,250 | $3,288 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $9,800 | $2,286 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 15 | $3,450 | $1,002 | 29.1% |
About Lauren Winters
Lauren Winters is a Acute Care healthcare provider based in Iowa Colony, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2022. The National Provider Identifier (NPI) number assigned to this provider is 1821716424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Winters has received a total of $1,290 in payments from pharmaceutical and medical device companies, with $544.24 received in 2024. These payments were reported across 51 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,290).
As a Medicare-enrolled provider, Winters has provided services to 34 Medicare beneficiaries, totaling 35 services with total Medicare billing of $3,288. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Iowa Colony, TX
- Active Since 08/19/2022
- Last Updated 08/19/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821716424
Products in Payments
- ENVARSUS (Drug) $277.53
- XIFAXAN (Drug) $170.88
- Rivfloza (Drug) $149.93
- MAVYRET (Drug) $133.63
- Epclusa (Drug) $123.21
- Cresemba (Drug) $95.39
- Lenvima (Drug) $91.27
- Prolastin-C Liquid (Biological) $45.17
- ULTOMIRIS (Biological) $43.65
- TEFLARO (Drug) $36.18
- TERLIVAZ (Drug) $28.43
- KEYTRUDA (Biological) $24.39
- LIVTENCITY (Drug) $21.78
- SOLIRIS (Biological) $16.24
- PEMAZYRE (Drug) $16.00
- AVYCAZ (Drug) $15.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.